Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 3,992 shares of the stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $64.73, for a total value of $258,402.16. Following the sale, the director now directly owns 92,499 shares in the company, valued at approximately $5,987,460.27. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
NASDAQ EXPO traded up $0.79 on Monday, hitting $63.83. 287,000 shares of the company’s stock were exchanged, compared to its average volume of 232,408. The stock has a 50-day moving average of $69.29 and a 200-day moving average of $63.19. The company has a current ratio of 3.53, a quick ratio of 3.60 and a debt-to-equity ratio of 0.05. Exponent, Inc. has a 52 week low of $46.00 and a 52 week high of $72.70. The stock has a market cap of $3.38 billion, a price-to-earnings ratio of 51.06 and a beta of 0.41.
Exponent (NASDAQ:EXPO) last released its earnings results on Thursday, October 17th. The business services provider reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.02. Exponent had a return on equity of 23.62% and a net margin of 19.88%. The firm had revenue of $101.50 million during the quarter, compared to analysts’ expectations of $100.17 million. During the same period in the prior year, the company earned $0.32 earnings per share. The company’s quarterly revenue was up 6.5% on a year-over-year basis. As a group, analysts predict that Exponent, Inc. will post 1.5 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 1.00%. The ex-dividend date of this dividend is Thursday, December 5th. Exponent’s payout ratio is presently 51.20%.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in EXPO. Nuveen Asset Management LLC bought a new stake in Exponent during the second quarter worth $34,946,000. FMR LLC lifted its stake in Exponent by 39.8% during the first quarter. FMR LLC now owns 993,288 shares of the business services provider’s stock worth $57,333,000 after purchasing an additional 282,530 shares during the last quarter. Morgan Stanley lifted its stake in Exponent by 82.4% during the second quarter. Morgan Stanley now owns 359,112 shares of the business services provider’s stock worth $21,023,000 after purchasing an additional 162,208 shares during the last quarter. Conestoga Capital Advisors LLC lifted its stake in Exponent by 4.4% during the second quarter. Conestoga Capital Advisors LLC now owns 2,422,012 shares of the business services provider’s stock worth $141,785,000 after purchasing an additional 102,845 shares during the last quarter. Finally, Nicholas Company Inc. bought a new stake in Exponent during the second quarter worth $5,204,000. Hedge funds and other institutional investors own 88.18% of the company’s stock.
EXPO has been the topic of a number of analyst reports. DA Davidson initiated coverage on Exponent in a research report on Wednesday, August 28th. They set a “neutral” rating on the stock. Zacks Investment Research raised Exponent from a “hold” rating to a “strong-buy” rating and set a $81.00 price target on the stock in a research report on Monday, September 23rd. BidaskClub downgraded Exponent from a “hold” rating to a “sell” rating in a research report on Thursday. Cantor Fitzgerald increased their price target on Exponent from $64.00 to $73.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Finally, SunTrust Banks increased their price target on Exponent from $70.00 to $81.00 and gave the stock a “buy” rating in a research report on Friday, September 20th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $76.75.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Recommended Story: What is the Rule of 72?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.